There is no product in the shopping cart, buy it!
| Size | Qty | Add To Basket |
|---|---|---|
| 1 mg | ||
| 2 mg | ||
| 5 mg |
| Product Overview | Recombinant Human MMP13 protein (NP_002418.1) is produced in Glycoengineered Human Cell Lines. This expression system is used for the production of glycoproteins and antibodies with human post-translational modifications. |
| Source | Glycoengineered Human Cell Lines |
| Species | Human |
| Tag | His-tag, FC-tag |
| Purity | >90%, determined by SDS-PAGE. |
| Endotoxin Level | Regular batch |
| Conjugation | None |
| Target | MMP13 |
| Full Name | Collagenase 3 |
| Gene ID | 4322 |
| Uniprot ID | P45452 |
| Accession Number | NP_002418.1 |
| Background | This gene encodes a member of the peptidase M10 family of matrix metalloproteinases (MMPs). Proteins in this family are involved in the breakdown of extracellular matrix in normal physiological processes, such as embryonic development, reproduction, and tissue remodeling, as well as in disease processes, such as arthritis and metastasis. The encoded preproprotein is proteolytically processed to generate the mature protease. This protease cleaves type II collagen more efficiently than types I and III. It may be involved in articular cartilage turnover and cartilage pathophysiology associated with osteoarthritis. Mutations in this gene are associated with metaphyseal anadysplasia. This gene is part of a cluster of MMP genes on chromosome 11. |
| Alternate Names | CLG3; MANDP1; MMP-13 |